ACST-1: Difference between revisions

Jump to navigation Jump to search
No change in size ,  17 October 2015
Tag: visualeditor
Tag: visualeditor
Line 14: Line 14:


=== 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease<ref name=":2" /> ===
=== 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease<ref name=":2" /> ===
* Selection of asymptomatic patients for carotid revascularization should be guided
* Selection of asymptomatic patients for carotid revascularization should be guided by an assessment of comorbid conditions, life expectancy, and other individual factors and should include a thorough discussion of the risks and benefits of the procedure with an understanding of patient preferences. (Class I; ''Level of Evidence: C'')
by an assessment of comorbid conditions, life expectancy, and other  
 
individual factors and should include a thorough discussion of the risks and benefits of the procedure with an understanding of patient preferences. (Class I; ''Level of Evidence: C'')
* It is reasonable to perform CEA in asymptomatic patients who have more than 70% stenosis of the internal carotid artery if the risk of perioperative stroke, MI, and death is low. (Class IIa; ''Level of Evidence: A'')
* It is reasonable to perform CEA in asymptomatic patients who have more than 70% stenosis of the internal carotid artery if the risk of perioperative stroke, MI, and death is low. (Class IIa; ''Level of Evidence: A'')
* In symptomatic or asymptomatic patients at high risk of complications for  
* In symptomatic or asymptomatic patients at high risk of complications for  
1,174

edits

Navigation menu